Objective To conduct a systematic review and meta-analysis of the efficacy and safety of fortification of human milk with human milk-based fortifier versus cow’s milk-based fortifier for use in ...

Surgifort fortifier is the latest addition to Prolacta’s line of human milk-based nutritional products, and it is the first fortifier indicated for use in term babies. Gastroschisis is a birth defect ...

Cow’s milk-based baby formula and milk fortifier products (like Enfamil™ and Similac ®) can greatly increase the risk of premature and low-birth-weight babies developing a potentially fatal intestinal ...

DUARTE, Calif., Feb. 25, 2025 /PRNewswire/ -- Prolacta Bioscience, the world’s leading hospital provider of 100% human milk-based nutritional products, today announced the U.S. Food and Drug ...

Surgifort fortifier is the latest addition to Prolacta's line of human milk-based nutritional products, and it is the first fortifier indicated for use in term babies. Gastroschisis is a birth ...

The human, pasteurized human milk fortifier is approved for term infants (> 37 weeks) following corrective surgery for the gastrointestinal disorder gastroschisis. The FDA has approved the first human ...

Surgifort® Human Milk Fortifier, Developed by Prolacta Bioscience, Is the First Human Milk-Based Nutritional Fortifier Indicated for Term Infants Surgifort fortifier is the latest addition to ...

You don’t have to be a francophile to appreciate France’s ability to formulate some impressive beauty goods — notably skin care products meant to support and improve the appearance of aging ...

Objective: This article studied the effect of breast milk supplemented with human milk fortifier (HMF) on the early recovery of infants after congenital cardiac surgery. Conclusion: Compared with ...